G

GIPathfinder

Rigidizing overtube enhances GI endoscope control

Manufacturing Engineer Co-op

Winter 2027Posted on 10/26/2026
$31.25 - $38.46/hr+ Bonus + Equity
Internship
Bachelor's
Burlingame, CA, USA
In PersonOn-site in Burlingame, California.
Manufacturing & Process EngineeringManufacturing Engineering

About the job

Requirements
  • Recent graduate or current undergraduate majoring in Mechanical Engineering or Biomedical/Biomechanical Engineering; related majors are acceptable with appropriate skills and interest to meet the job requirements.
  • Significant hands-on engineering experience and aptitude.
  • Demonstrated interest in contributing to a small medical-device startup.
Responsibilities
  • Investigate yield loss and nonconformances through root cause analysis.
  • Develop and implement solutions for product enhancements, cost reduction, and production scaling.
  • Assist with design and process improvements, validation activities, and related qualifications.
  • Author test methods, protocols, and detailed technical reports.
  • Perform analytical calculations.
  • Author and update manufacturing process instructions to reduce risk and optimize production performance.
  • Leverage prototyping for process improvements.
  • Represent Manufacturing on cross-functional teams and ensure proper design for manufacturing.
  • Generate detailed computer-aided design component and assembly drawings using SolidWorks.
  • Design, document, troubleshoot, and implement new and upgraded production equipment and fixturing.
  • Participate in supplier selection and qualification, and in material review and CAPA efforts.
  • Apply a risk-driven approach to quality and compliance with risk management policies, practices, and Good Manufacturing Practices.
  • Contribute to the company's intellectual property position.
  • Work within a regulated, quality-system-driven, FDA-monitored medical-device environment.
  • Assist with testing products on the bench, in tissue models, and in live animals.
  • Develop test methods, protocols, and reports to evaluate components, systems, and processes.

About the company

Pathfinder develops a rigidizing overtube to improve endoscope control during gastrointestinal (GI) procedures. It addresses endoscope looping by allowing the overtube to instantly switch from flexible to rigid, stabilizing the endoscope and making navigation easier in complex cases and altered anatomy. The product works by being placed over the endoscope during a procedure; in flexible mode it slides with the scope, and when rigidity is needed, it becomes stiff to prevent looping, guiding the scope more precisely. Pathfinder differentiates itself from competitors by offering a quick toggle between flexible and rigid states, focusing specifically on GI procedures such as luminal therapeutics and ERCP, and targeting improved procedural efficiency and success rates in hospitals and clinics. The company aims to improve procedural outcomes, shorten procedure times, and enhance patient care by providing a reliable solution to endoscope looping that supports clinicians in difficult cases.

Company Size

51-200

Company Stage

Series D

Total Funding

$97M

Headquarters

Burlingame, California

Founded

2016

Get referred to GIPathfinder

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • May 2026 CARE-1 showed 100% cecal intubation and zero adverse events.
  • DDW 2026 presence and late-breaking data signal active commercial and clinical momentum.
  • 2024’s $97 million Series D funded expansion, while Pathfinder usage reportedly keeps growing.

What critics are saying

  • Triton remains investigational in 2026; commercial success depends on future FDA clearance.
  • GIPathfinder’s clinical story relies on Neptune Medical; branding confusion can dilute employer credibility.
  • Single-product dependence makes Pathfinder vulnerable if adoption stalls or competitor overtubes outperform.

What makes GIPathfinder unique

  • Pathfinder’s Dynamic Rigidization™ toggles flexible-to-rigid instantly during GI procedures.
  • FDA-cleared Pathfinder reached market in 2021, unlike most experimental endoscopy robotics.
  • Olympus participated in Neptune Medical’s 2024 Series D, validating strategic relevance.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Paid Vacation
  • Paid Holidays
  • Flexible Work Hours
  • Remote Work Options
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Professional Development Budget
  • Conference Attendance Budget
  • Stock Options
  • Company Equity
  • Wellness Program

Growth & Insights and Company News

6 month growth

1%

1 year growth

1%

2 year growth

22%
WTWH Media LLC
Oct 4th, 2024
Robotics Investments Near $1B In August

Listen to this articleSwiss-Mile raised $22M in August 2024 for its wheeled quadruped. Fifty producers of robots and robotics enabling technologies received funding in August 2024, pulling in a total of approximately $1 billion. This figure is on par with the $1.2 billion average The Robot Report has tracked each of the previous 12 months. Investment targeted to robotics companies for the first eight months of 2024 equals about $10.86 billion. You can follow The Robot Report‘s investment section here. The largest investments in August were secured by developers of autonomous driving technologies

Business Wire
Aug 17th, 2024
Neptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular

Neptune Medical announces $97 million in Series D financing, along with the spinout of its Jupiter Endovascular subsidiary.